Dr. Reddy's Laboratories reported consolidated revenue growth of 15.6% for Q4 FY27, led by its Infrastructure division, which contributed 27.2% of the total. Operating margin held at 10.7%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

The numbers

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2030, and disclosed that 27.2% of electricity at its main sites now comes from renewable sources under long-term contracts.

Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.

Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 27.2% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.

“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”

Expansion and capital allocation

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $476 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

A new long-term agreement with Bharat Forge anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Customers, contracts and exports

Export performance was a bright spot. Shipments to South Korea rose 15.6%, helped by certification wins and shorter lead times from Hazira. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

The company also announced a new facility near Hazira, designed to add about 1,314 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Risks and analyst view

On the post-results call, management said the order book now stands at $8.9 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in South Korea and France. The chief financial officer described visibility as the best in five years.